InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Explore the detailed record of transactions filed by HANLY ANN M., Chief Technology Officer. Officer active across 1 company, notably Vir Biotechnology, Inc.. Cumulatively, 4 disclosures have been recorded. Split: 2 buys · 1 sell. Total volume traded: €63k. Activity tracked since 29 November 2021. The latest transaction was filed on 30 March 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
2,627 shares@ US$26.23730.0073% mcap98.6% of flowCommon StockSEC:0001209191-22-021728:0
53,500 shares0Common StockSEC:0001209191-22-012955:0
11.52 shares@ US$43.390.0001% mcap0.7% of flowCommon StockSEC:0001209191-21-067380:0
Ideal exit: 26 Aug 2022 (T+270)
11.52 shares@ US$43.390.0001% mcap100.0% of flowCommon StockSEC:0001209191-21-067380
Ideal exit: 26 Aug 2022 (T+270)
4 of 4 declarations
About HANLY ANN M.
Ann M. Hanly is Chief Technology Officer at Vir Biotechnology, Inc. She is responsible for leading the company's technological initiatives. Her expertise in biotechnology is essential in supporting innovation and the development of new products.
